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1.1  Background 
 The post-war period of the late 1940s and the 1950s was a productive time for 
developments in the use of radionuclides to diagnose and treat human disease. The 
pioneers of these developments in the UK were eminent scientists such as Norman 
Veall, Russell Herbert, WV Mayneord, and John Mallard who carried out research 
using radiopharmaceuticals and designed and built simple homemade detection sys-
tems [ 1 ,  2 ]. The fi eld developed rapidly but failed initially to capture the imagina-
tion of clinicians other than endocrinologists such as Edward McGirr (second 
President of the BNMS) who used 131I to study and treat thyroid disorders. 
Infl uenced by progress reported at international meetings, the availability of com-
mercially built scanners and the increasing access to radioisotopes other than I-131, 
things were changing in the UK and elsewhere. Progress with radioisotopes had 
largely been the preserve of Medical Physics Departments but by 1960 it was rec-
ognised that the move of radioisotopes from bench to bedside necessitated medical 
leadership of the new discipline of ‘Nuclear Medicine’, a descriptor imported from 
North America. The 1960s saw the appointment of the fi rst consultant physicians in 
Nuclear Medicine in the UK. 
1.2  The Original Four 
 Against this changing landscape, four clinicians with an interest in Nuclear Medicine, 
Steve Garnett, David Keeling, Ralph McCready and Edward Williams met at the 
Prince Alfred pub in Queensway, London (Fig.  1.1 ) on Tuesday 19th July 1966 to 
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2discuss the future professional situation of physicians working in Nuclear Medicine 
[ 2 ]. The group formed the Nuclear Medicine Society (NMS) and resolved to hold 4 
meetings a year. This was a courageous move leaving behind, as they did, the protec-
tive environment of more established medical associations. The NMS meetings were 
held initially at the Middlesex Hospital, London and took the form of evening meet-
ings followed by a buffet supper. Initially there were no offi cers but Ralph McCready 
took on the role as Secretary and David Keeling produced a short newsletter. The fi rst 
AGM was held in December 1966 and the rules and byelaws were agreed and 
approved at a meeting of the NMS at the Middlesex Hospital on 6th October 1967. 
The fi rst formal election of NMS offi cers took place in December 1967. Clive Hayter 
(Leeds) was elected as fi rst President, Ralph McCready was confi rmed as the 
Honorary Secretary and Steve Garnett (Southampton) as Treasurer. At this time the 
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3fl edgling society numbered 25 members and in January 1968 subscriptions were 
levied at £1 increasing to £2 by October of that year. In recognition of the many 
national Nuclear Medicine specialist groups that had formed globally, an EGM was 
convened on 19 November 1969, and the meeting voted to change its name from the 
‘Nuclear Medicine Society’ to the ‘British Nuclear Medicine Society’ (BNMS) [ 3 ].
1.3  First Steps 
 By the late 1960s interest in Nuclear Medicine in the UK was growing fast and in 
June 1969 the Royal College of Physicians held a meeting entitled ‘Advances in the 
Application of Physics in Medicine’ incorporating advances in Nuclear Medicine. 
The May 1970 BNMS Newsletter gave details of the London University Nuclear 
Medicine MSc course that commenced later that year. In 1971, Edward Williams, 
then head of the Institute of Nuclear Medicine at the Middlesex Hospital, was 
elected BNMS President and the same year became the fi rst UK Professor of 
Nuclear Medicine. A paper given by Edward Williams at the ‘Whither Nuclear 
Medicine’ meeting at the Royal College of Surgeons in Lincoln’s Field in May 1971 
helped foster the association with internal medicine. By 1972 there were 140 recti-
linear scanners in the UK and 30 gamma cameras, a remarkable advance given that 
the fi rst UK commercial scanner had been installed in 1958 at the Royal Marsden 
[ 3 ] The success of clinical Nuclear Medicine highlighted tensions between the vari-
ous professional bodies involved in Nuclear Medicine in the UK particularly over 
the matter of the HPA document ‘Organisation of Hospital Radioisotope Services 
(Nuclear Medicine) in the UK’ [ 3 ]. These diffi culties were resolved by discussion 
and the groups have continued to work collaboratively over the years. Important 
associations were formed early on between the BNMS and international organisa-
tions such as the World Federation of Nuclear Medicine and Biology (WFNMB). In 
1971 the BNMS was invited to sign as the UK representative to the WFNMB. In 
June 1974, Desmond Croft attended the ENMS meeting at Clermont-Ferrand and 
signed up the BNMS as the specialist NM society representing the UK [ 3 ]. Such 
developments helped strengthen and establish the BNMS as the recognised profes-
sional organisation devoted to Nuclear Medicine in the UK. 
1.4  Annual Meetings 
 By the early 1970s efforts were concentrated on the creation of an annual meeting 
and AGM. The fi rst annual meeting of the BNMS took place in 1973 in the Windeyer 
Building at the Middlesex Hospital and included a small commercial exhibition [ 4 ]. 
By 1975, and for economic reasons, the annual meeting [ 3 ] was held at the University 
of London Student’s union in Malet Street where the registration fee was £1 (£2 for 
non-members). The 1976 annual meeting was a 2-day conference held in association 
with the HPA where 24 proffered papers were presented [ 5 ]. The 1978 BNMS annual 
meeting was held jointly with the ENMS and SNME (the forerunner organisations of 
1 History of the BNMS 1966–2016
4the EANM) prompting a move to Imperial College where the venue remained until 
1995. The single exception to this was 1985 (the year of the joint ENMS/SNME/
BNMS meeting at the Barbican) when a 1-day BNMS meeting was held at the 
University of Manchester Institute of Science and Technology during April. The 
1980 annual meeting was the fi rst UK meeting to be held over 3 days. The newsletter 
commented that one of the strengths of the meeting was ‘the enthusiasm of the com-
mercial exhibitors to display and discuss their wares’ [ 6 ]. By 1986 at the 14th annual 
meeting, there were 162 proffered papers of which 119 were accepted and it was 
generally agreed that the standard of the scientifi c papers was high [ 5 ]. A central 
feature of the annual meeting is the guest lecture. Of the many distinguished lectures 
over the years, the BNMS were honoured to have Professor Henry Wagner deliver 
the 1987 guest lecture entitled ‘Imaging the Chemistry of Mental Illness.’ 
 The need for space to accommodate the commercial exhibition necessitated a 
move away from Imperial College to more suitable venues. In 1996 the annual 
meeting was held in Brighton and thereafter at various venues including Brighton, 
Manchester and Edinburgh until 2009. The delegate numbers peaked at 768 at 
Brighton in 2000. However, the spiralling costs of the larger centres meant that it 
was no longer fi nancially viable to continue at large city venues and a decision was 
taken to alternate between Harrogate and Brighton where the venue hire was more 
affordable during the period 2009–2015. The 2016 Annual Meeting will be held in 
Birmingham where fi ttingly the President is Dr Alp Notghi. 
1.5  Joint Meetings with EANM 
 Since its formation, the BNMS has held four joint meetings with the EANM in the 
UK. These were in 1978 at Imperial College, 1985 at the Barbican Centre, 1997 at 
the SECC Glasgow and 2011 at the ICC Birmingham. Over 3,000 delegates attended 
the Barbican Centre in 1985 where the Congress President was Keith Britton and 
the BNMS President was Keith Harding. The Congress President at the Glasgow 
Meeting in 1997 was Jim McKillop and the BNMS President was Harry Gray. Over 
5,400 participants attended the 2011 Birmingham meeting where the local organiser 
was Alan Perkins, the fi rst non-medical President of the BNMS. 
1.6  Membership 
 As a registered charity the BNMS is the only independent multi-disciplinary profes-
sional forum in the UK devoted to all aspects of Nuclear Medicine. The Board of 
Trustees of the BNMS (known as the Council) is responsible for the charity. Its 
members include clinical scientists, nuclear medicine physicians, nurses, radiolo-
gists, radiopharmacists and technologists. Initially, full membership of the BNMS 
was open only to medically qualifi ed persons although Council had the right to admit 
to membership individuals thought to have a valid claim. At the AGM in 1972 the 
rules and byelaws were changed to allow non-medical colleagues to become full 
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5members of the BNMS [ 3 ]. As an means of widening membership further, the 
Charities Commission was approached and gave permission in 1980 to establish a 
new category entitled ‘associate membership’ open to all scientists, pharmacists, 
technicians and medical staff not eligible for full membership. The initial associate 
membership fee was set at £8 allowing access to the newsletter section of the journal 
and reduced fees at BNMS meetings [ 3 ]. As a result of this and refl ecting the grow-
ing interest in Nuclear Medicine, BNMS membership increased from 220 in 1982 to 
752 (including 195 associate members) in the year 2000. The membership numbers 
have subsequently decreased but fl uctuate between 450 and 500 members at present. 
The growth of the BNMS necessitated a change to the legal status of the organisation 
and in 2012 following a successful application to Companies House, the BNMS was 
incorporated under the Companies Act 2006 as a company limited by guarantee. 
1.7  Aims and Objectives 
 While the agenda of early BNMS council meetings was dominated of necessity by 
the formation of its rules and byelaws and the arrangement of its scientifi c meetings, 
the matters discussed by council included issues of national concern such as staff 
training (technical and medical), advice to government bodies on the registration, 
authorisation and safe use of radioisotopes in medicine, and collaboration with 
other professional organisations such as HPA and BIR [ 3 ]. The business of these 
fi rst BNMS Council meetings helped shape the aims and objectives of the Society 
that were subsequently crystallised and set out in the Articles of Association and 
now captured in the BNMS strategic plan 2010–2013 [ 7 ]. To help Council achieve 
its objectives, there are a number of Committees or Groups that report to Council. 
These include Professional Standards, Education, Science, Research & Innovation, 
Public Relations, Therapy and PET-CT groups. The administrative functions of the 
BNMS were ably supported by a number of individuals but notably by Sue Hatchard 
who was administrative secretary between 1986 until 2013. Sue ran the BNMS from 
the offi ce in Regent House, SE London and on her retiral, the BNMS Offi ces moved 
to the Jubilee Campus at Nottingham University where Charlotte Weston is the 
Chief Executive Offi cer. 
1.8  The Journal 
 A signifi cant development for Nuclear Medicine in general and the BNMS in par-
ticular was the creation of Nuclear Medicine Communications. The journal was 
formed to facilitate rapid communication of information within the international 
community. The fi rst issue of Nuclear Medicine Communications was published in 
1980 in association with the BNMS [ 8 ]. The success story that is Nuclear Medicine 
and the part played by the BNMS in its remarkable progress in the UK can be seen 
in the pages of NMC, as well as at scientifi c meetings of the BNMS and on its 
webpages. 
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7 Brian  Neilly  I graduated MB ChB from the University of Dundee and completed my house jobs 
with Dr Robert Fife in Medicine and with Professor David Carter in Surgery at Glasgow Royal 
Infi rmary (GRI). I was offered a post in surgery but preferred the physician route and joined the 
medical SHO rotation at GRI and completed the MRCP examination. A medical registrar post fol-
lowed during which I completed research for my MD in Cor Pulmonale after which I undertook a 
research fellowship in sleep medicine at the University of Pennsylvania in Philadelphia. On my 
return to the UK I was appointed Senior Registrar in Internal Medicine and Nuclear Medicine at 
GRI where my training was with two former Presidents of the BNMS, Professor Jim McKillop and 
Dr Harry Gray of the University Medical Unit. I was appointed Consultant Physician with an inter-
est in Nuclear and Respiratory Medicine at Glasgow Royal Infi rmary in 1995 and, being a physi-
cian at heart, still enjoy the challenge of the acute medical take and continuing care of ward 
patients. Due to my interest in Nuclear Medicine training I have held posts as Chair of the STC, 
SAC and ICSCNM and am external examiner to the London Nuclear Medicine MSc. In line with 
my continued interest in pulmonary embolism, I was a co-author of the EANM Guidelines on VQ 
SPECT in Pulmonary Embolism 2009. As President of the BNMS from 2012 to 2014 I was lead 
author of the Medical Radioisotopes Report 2014. As Chair of the ICSCNM I led the successful 
initiative to apply to the GMC for Curriculum Change in Nuclear Medicine Training in the UK, 
commenced 2015. 
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 My thanks to Ralph McCready, Andrew Hilson, Harry Gray and of course the notes by David 
Keeling on the fi rst 10 years, for providing detail on the historical background of the BNMS. 
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